Century Therapeutics Statistics
Total Valuation
IPSC has a market cap or net worth of $43.67 million. The enterprise value is -$60.28 million.
Important Dates
The next estimated earnings date is Tuesday, November 4, 2025, before market open.
Earnings Date | Nov 4, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
IPSC has 86.39 million shares outstanding. The number of shares has increased by 29.80% in one year.
Current Share Class | 86.39M |
Shares Outstanding | 86.39M |
Shares Change (YoY) | +29.80% |
Shares Change (QoQ) | +0.16% |
Owned by Insiders (%) | 4.43% |
Owned by Institutions (%) | 23.69% |
Float | 45.36M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.38 |
Forward PS | n/a |
PB Ratio | 0.21 |
P/TBV Ratio | 0.25 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.72, with a Debt / Equity ratio of 0.25.
Current Ratio | 10.72 |
Quick Ratio | 10.47 |
Debt / Equity | 0.25 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -10.78% and return on invested capital (ROIC) is -6.64%.
Return on Equity (ROE) | -10.78% |
Return on Assets (ROA) | -5.11% |
Return on Invested Capital (ROIC) | -6.64% |
Return on Capital Employed (ROCE) | -10.62% |
Revenue Per Employee | $760,853 |
Profits Per Employee | -$155,187 |
Employee Count | 150 |
Asset Turnover | 0.33 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, IPSC has paid $1.77 million in taxes.
Income Tax | 1.77M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.05% in the last 52 weeks. The beta is 1.78, so IPSC's price volatility has been higher than the market average.
Beta (5Y) | 1.78 |
52-Week Price Change | -65.05% |
50-Day Moving Average | 0.55 |
200-Day Moving Average | 0.72 |
Relative Strength Index (RSI) | 46.23 |
Average Volume (20 Days) | 739,859 |
Short Selling Information
The latest short interest is 1.46 million, so 1.69% of the outstanding shares have been sold short.
Short Interest | 1.46M |
Short Previous Month | 1.34M |
Short % of Shares Out | 1.69% |
Short % of Float | 3.22% |
Short Ratio (days to cover) | 1.54 |
Income Statement
In the last 12 months, IPSC had revenue of $114.13 million and -$23.28 million in losses. Loss per share was -$0.27.
Revenue | 114.13M |
Gross Profit | 4.09M |
Operating Income | -28.66M |
Pretax Income | -131.64M |
Net Income | -23.28M |
EBITDA | -15.62M |
EBIT | -28.66M |
Loss Per Share | -$0.27 |
Full Income Statement Balance Sheet
The company has $155.84 million in cash and $51.48 million in debt, giving a net cash position of $104.36 million or $1.21 per share.
Cash & Cash Equivalents | 155.84M |
Total Debt | 51.48M |
Net Cash | 104.36M |
Net Cash Per Share | $1.21 |
Equity (Book Value) | 209.90M |
Book Value Per Share | 2.43 |
Working Capital | 145.22M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$114.77 million and capital expenditures -$142,000, giving a free cash flow of -$114.91 million.
Operating Cash Flow | -114.77M |
Capital Expenditures | -142,000 |
Free Cash Flow | -114.91M |
FCF Per Share | -$1.33 |
Full Cash Flow Statement Margins
Gross margin is 3.58%, with operating and profit margins of -25.11% and -20.40%.
Gross Margin | 3.58% |
Operating Margin | -25.11% |
Pretax Margin | -18.85% |
Profit Margin | -20.40% |
EBITDA Margin | -13.69% |
EBIT Margin | -25.11% |
FCF Margin | n/a |
Dividends & Yields
IPSC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -29.80% |
Shareholder Yield | -29.80% |
Earnings Yield | -52.80% |
FCF Yield | -260.66% |
Analyst Forecast
The average price target for IPSC is $3.33, which is 558.75% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $3.33 |
Price Target Difference | 558.75% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
IPSC has an Altman Z-Score of -2.16 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -2.16 |
Piotroski F-Score | 3 |